Skip to content
Search

Latest Stories

22-year-old MPharm graduate receives pharmacy memorial prize

Callom Short, who recently graduated with an MPharm degree from the University of Sunderland, received the Professor Roz Anderson Memorial Award this year.

The annual prize is given to a student who shows an outstanding performance throughout the MPharm degree, honouring the memory of Professor Anderson, an inspirational scientist dedicated to improving the treatment of patients with a rare life-threatening genetic disease.


Callom, 22, from Gateshead, has been working as a domiciliary care worker across Gateshead in patient care for the last six years and then last year, began work with dementia patients at Wardley Gate Care Centre, during one of the most challenging times for the sector.

“I started work just as Covid-19 hit and it was a massive experience, seeing the impact the disease had on patients and their families was incredibly challenging, I was dealing with lots of difficult situations, but it certainly helped develop my interpersonal skills," he said.

“This experience also helped me develop my confidence in helping others and show compassion.”

These skills, Callom says, will be invaluable when he begins his pre-registration year at Sunderland Royal Hospital, working not just in the dispensary, but also on the GP wards.

He added: “This last year has been a year like no other but thankfully I was so well supported by the university through online learning, all the materials we needed were there for us.

Professor Anderson lost her battle with cancer in 2018. She was a Professor of Pharmaceutical Chemistry at Sunderland. In her 31-year career as a researcher at the University, she worked on the treatment of Alzheimer's disease, diagnosis of bacterial infections, psoriasis, and cancer, but her particular passion was the battle against the rare genetic disorder Cystinosis.

Dr Adrian Moore, head of Pharmacy and Pharmaceutical Sciences, said: “Callom has fully embodied the spirit of Roz’s work, demonstrating a wide appreciation of how fundamental science informs the understanding of how medicines work and are developed for the benefit of patients; it has been a genuine pleasure to be involved in his education.

“My congratulations go out to Callom as this award is very well deserved in recognition of all that he has done and, I’m sure, will continue to do as his professional career develops.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less